112 related articles for article (PubMed ID: 7924180)
21. Pravastatin, simvastatin, and lovastatin for lowering serum cholesterol concentrations.
Med Lett Drugs Ther; 1992 Jun; 34(872):57-8. PubMed ID: 1593973
[No Abstract] [Full Text] [Related]
22. [Statins (HMG-CoA reductase inhibitors), cholesterol and stroke].
Marta-Moreno J; Echeandia C; Oliveros-Cid A; Figuerola A; Mola S
Rev Neurol; 1998 Nov; 27(159):827-30. PubMed ID: 9859160
[TBL] [Abstract][Full Text] [Related]
23. [Diabetes mellitus, hypercholesterolemia, and therapeutic prospects with simvastatin. General considerations and personal contribution].
Pipicelli G; Pentimone F; Frustaci G; Notarangelo R; Beghè F
Minerva Med; 1992 Dec; 83(12):819-25. PubMed ID: 1491762
[TBL] [Abstract][Full Text] [Related]
24. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
Farnier M; Bonnefous F; Debbas N; Irvine A
Arch Intern Med; 1994 Feb; 154(4):441-9. PubMed ID: 8117177
[TBL] [Abstract][Full Text] [Related]
25. [Effect of a long-term treatment with simvastatin, an inhibitor of HMG-CoA reductase, in dyslipidemic patients at high risk].
Strano A; Novo S; Notarbartolo A; Davì G; Abrignani MG; Alaimo G; Averna MR; Barbagallo CM; Marino G
Cardiologia; 1989 Dec; 34(12):1027-33. PubMed ID: 2634479
[TBL] [Abstract][Full Text] [Related]
26. Cholesterol content of the rat lens is lowered by administration of simvastatin, but not by pravastatin.
De Vries AC; Vermeer MA; Bredman JJ; Bär PR; Cohen LH
Exp Eye Res; 1993 Apr; 56(4):393-9. PubMed ID: 8500554
[TBL] [Abstract][Full Text] [Related]
27. The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.
Eckernäs SA; Roos BE; Kvidal P; Eriksson LO; Block GA; Neafus RP; Haigh JR
Br J Clin Pharmacol; 1993 Mar; 35(3):284-9. PubMed ID: 8471404
[TBL] [Abstract][Full Text] [Related]
28. [Changes in lipid status during pravastatin treatment].
Craveri A; Colombo L; Citella C; Pedrazzini L; Altomare S; Giavardi L; Picollo S; Vignati A; Lanfredini M
Minerva Med; 1992 Nov; 83(11):695-703. PubMed ID: 1461540
[TBL] [Abstract][Full Text] [Related]
29. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial.
Brown WV; Bays HE; Hassman DR; McKenney J; Chitra R; Hutchinson H; Miller E;
Am Heart J; 2002 Dec; 144(6):1036-43. PubMed ID: 12486428
[TBL] [Abstract][Full Text] [Related]
31. [The HMG-CoA reductase inhibitors simvastatin and pravastatin. No indication for side effects in use on humans].
Schmidt J; Schmitt C; Hockwin O
Fortschr Ophthalmol; 1991; 88(6):843-5. PubMed ID: 1794817
[TBL] [Abstract][Full Text] [Related]
32. Influence of cholesterol-lowering on plasma membrane lipids and function.
Lijnen P; Echevaría-Vázquez D; Petrov V
Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
[TBL] [Abstract][Full Text] [Related]
33. [Effect of HMG-CoA reductase inhibitors on the erythrocyte membrane].
Rabini RA; Antosiewicz J; Staffolani R; Polenta M; Testa I; Mazzanti L
Boll Soc Ital Biol Sper; 1991 Feb; 67(2):129-35. PubMed ID: 1653578
[TBL] [Abstract][Full Text] [Related]
34. Treating hypercholesterolaemia with HMG CoA reductase inhibitors: a direct comparison of simvastatin and pravastatin.
Lintott CJ; Scott RS; Sutherland WH; Bremer J
Aust N Z J Med; 1993 Aug; 23(4):381-6. PubMed ID: 8240151
[TBL] [Abstract][Full Text] [Related]
35. Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia.
Branchi A; Rovellini A; Sommariva D; Gugliandolo AG; Fasoli A
Thromb Haemost; 1993 Aug; 70(2):241-3. PubMed ID: 8236126
[TBL] [Abstract][Full Text] [Related]
36. [Porphyria cutanea tarda induced by HMG CoA reductase inhibitors: simvastatin, pravastatin].
Perrot JL; Guy C; Bour Guichenez G; Amigues O; Servoz J; Cambazard F
Ann Dermatol Venereol; 1994; 121(11):817-9. PubMed ID: 7631993
[TBL] [Abstract][Full Text] [Related]
37. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of simvastatin and pravastatin in patients with primary hypercholesterolemia (multicountry comparative study). The European Study Group.
Am J Cardiol; 1992 Nov; 70(15):1281-6. PubMed ID: 1442579
[TBL] [Abstract][Full Text] [Related]
39. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
[TBL] [Abstract][Full Text] [Related]
40. Effect of hydroxymethylglutaryl-CoA reductase inhibitors on the functional properties of erythrocyte membranes.
Rabini RA; Polenta M; Staffolani R; Tocchini M; Signore R; Testa I; Mazzanti L
Exp Mol Pathol; 1993 Aug; 59(1):51-7. PubMed ID: 8262165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
